Johnson & Johnson JNJ
275.62 USD +9.45 (+3.55%)
Nov 4, 2026, 1:56 PM EST
267.67 Day range 275.71
186.00 52-week range 278.43
- YTD
- +33.18%
- 1 year
- +47.50%
Analyst view
Consensus: buy
Buy
Price target (mean) 279.41 +1.4% upside
Now 275.62
- Target (low)
- 190.00
- Target (mean)
- 279.41
- Target (high)
- 320.00
Ratings (0m) 23 16 buy · 6 hold · 1 sell
- Strong buy5
- Buy11
- Hold6
- Sell1
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 23
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.92 | 2.86 – 2.97 | 2.46 | +18.5% | 26.42B | +7.6% | 17 |
| Next quarter | 2.68 | 2.57 – 2.87 | 2.70 | -0.9% | 25.55B | +6.2% | 7 |
| Current year | 11.12 | 11.05 – 11.28 | 10.79 | +3.1% | 101.22B | +7.5% | 21 |
| Next year | 11.62 | 10.65 – 13.34 | 11.12 | +4.5% | 107.75B | +6.5% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 16, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 15, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 14, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Oct 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 29, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Sep 2, 2026 | UBS | Maintained | Buy | Buy |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 3, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 17, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Jul 16, 2026 | Raymond James | Maintained | Outperform | Outperform |
| Jul 16, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 16, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 13, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 10, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 8, 2026 | Citigroup | Maintained | Buy | Buy |
| Jun 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 13, 2026 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Apr 15, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 15, 2026 | Stifel | Maintained | Hold | Hold |
| Apr 15, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 30, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
